SHANKUS PHARMA PRIVATE LTD
Overview
SHANKUS PHARMA PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering AGOMELATINE IH; DULOXETINE HYDROCHLORIDE EP/BP; DULOXETINE HYDROCHLORIDE USP; LERCANIDIPINE HYDROCHLORIDE IH; LINAGLIPTIN IH; MOXIFLOXACIN HYDROCHLORIDE EP BP.
Core services & business areas
Active pharmaceutical ingredients supplied
Substances SHANKUS PHARMA PRIVATE LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
SHANKUS PHARMA PRIVATE LTD holds 7 active (7 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- DULOXETINE HYDROCHLORIDE USPActive2026-01-07
- DULOXETINE HYDROCHLORIDE EP/BPActive2025-12-09
- AGOMELATINE IHActive2025-11-07
- LINAGLIPTIN IHActive2025-09-29
- LERCANIDIPINE HYDROCHLORIDE IHActive2025-09-29
- MOXIFLOXACIN HYDROCHLORIDE USPActive2025-09-26
- MOXIFLOXACIN HYDROCHLORIDE EP BPActive2025-09-26
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to SHANKUS PHARMA PRIVATE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this SHANKUS PHARMA PRIVATE LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.